We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+0.14%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$150M
AUM Growth
+$20.3M
(+16%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
10.5%
Top 10 Holdings %
Top 10 Hldgs %
9.04%
Holding
664
New
292
Increased
44
Reduced
53
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.11M |
| 3 |
Nike
NKE
|
+$1.03M |
| 4 |
PAY
Verifone Systems Inc
PAY
|
+$959K |
| 5 |
MON
Monsanto Co
MON
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.43M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.19M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.41M |
| 4 |
Enterprise Products Partners
EPD
|
+$1.02M |
| 5 |
Magna International
MGA
|
+$933K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.63% |
| 2 | Healthcare | 14.32% |
| 3 | Technology | 11.92% |
| 4 | Industrials | 11.68% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Amazon
AMZN
$2.5T
| $297K | 0.2% |
+10,000
| New | +$284K |
|
227
LivaNova
LIVN
$4.29B
| $297K | 0.2% |
+5,500
| New | +$306K |
|
228
Meta Platforms (Facebook)
META
$1.52T
| $297K | 0.2% |
2,600
-700
| -21% | -$73.9K |
|
229
American Financial Group
AFG
$11.9B
| $296K | 0.2% |
+4,200
| New | +$288K |
|
230
Labcorp
LH
$24.3B
| $293K | 0.2% |
2,910
+233
| +9% | +$22.3K |
|
|
WRK
231
DELISTED
WestRock Company
WRK
| $293K | 0.2% |
8,324
+3,218
| +63% | +$105K |
|
|
WRI
232
DELISTED
Weingarten Realty Investors
WRI
| $293K | 0.2% |
7,800
+400
| +5% | +$14.1K |
|
|
EGN
233
DELISTED
Energen
EGN
| $293K | 0.2% |
+8,000
| New | +$248K |
|
234
Expedia Group
EXPE
$31.4B
| $291K | 0.19% |
+2,700
| New | +$288K |
|
|
CTXS
235
DELISTED
Citrix Systems Inc
CTXS
| $291K | 0.19% |
+4,646
| New | +$263K |
|
236
Novartis
NVS
$294B
| $290K | 0.19% |
+4,464
| New | +$304K |
|
|
VAR
237
DELISTED
Varian Medical Systems, Inc.
VAR
| $288K | 0.19% |
+4,105
| New | +$279K |
|
|
HDS
238
DELISTED
HD Supply Holdings, Inc.
HDS
| $288K | 0.19% |
+8,700
| New | +$240K |
|
|
EEP
239
DELISTED
Enbridge Energy Partners
EEP
| $288K | 0.19% |
+15,700
| New | +$277K |
|
|
HRC
240
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $287K | 0.19% |
+5,700
| New | +$269K |
|
241
Open Text
OTEX
$5.43B
| $285K | 0.19% |
+11,000
| New | +$265K |
|
242
Toro Company
TTC
$8.9B
| $284K | 0.19% |
+6,600
| New | +$254K |
|
243
Teradata
TDC
$2.7B
| $283K | 0.19% |
+10,800
| New | +$267K |
|
244
Trustmark
TRMK
$2.73B
| $283K | 0.19% |
+12,300
| New | +$271K |
|
|
DISH
245
DELISTED
DISH Network Corp.
DISH
| $282K | 0.19% |
6,100
-7,300
| -54% | -$352K |
|
|
XLNX
246
DELISTED
Xilinx Inc
XLNX
| $280K | 0.19% |
5,900
-4,900
| -45% | -$230K |
|
247
Brink's
BCO
$5.01B
| $279K | 0.19% |
8,300
-4,200
| -34% | -$124K |
|
|
SPWR
248
DELISTED
SunPower Corporation Common Stock
SPWR
| $279K | 0.19% |
+19,088
| New | +$297K |
|
249
BCE
BCE
$19.9B
| $278K | 0.19% |
+6,100
| New | +$255K |
|
|
FMI
250
DELISTED
Foundation Medicine, Inc.
FMI
| $278K | 0.19% |
15,300
+3,600
| +31% | +$58K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fox Run Management held 664 positions worth $150M, up 16% from $129M the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Fox Run Management deployed $15.7M of net new capital in Q1 2016, opening 292 new positions and adding to 44 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.43M trimmed.
- Fox Run Management's largest Q1 2016 buy was Regeneron Pharmaceuticals: 2,700 shares worth $973K.
- Fox Run Management added most to Hologic in Q1 2016, an estimated $823K increase.
- Fox Run Management's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.43M.
- Fox Run Management fully exited Enterprise Products Partners in Q1 2016, selling an estimated $1.02M.
- Fox Run Management's ten largest holdings make up 9% of its $150M portfolio in Q1 2016.
- Fox Run Management opened 292 new positions and closed 273 in Q1 2016.
- Fox Run Management's portfolio value rose 16% quarter-over-quarter to $150M.
Based on Fox Run Management's 13F filing for Q1 2016, filed 18 Apr 2016.